Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-02-01

Clinical Trial Update: Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine for Pain Management [Phase 4]

View source ↗

Summary

Phase 4 trial comparing local anesthetic infusion pump to DepoFoam bupivacaine for pain management was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Depofoam bupivacaine (bupivacaine)

Snippet

Sponsor: Henry Ford Health System | Conditions: Pain | Phase 4 | Status: WITHDRAWN